A journey to parenthood: shedding light on fertility for Canadian Infertility Awareness Week

April 22 to 27 is Canadian Infertility Awareness Week, and EMD Serono, Canada is bringing attention to the far-reaching impact of infertility to encourage couples to educate themselves on reproductive health

22 Apr 2019 | MISSISSAUGA, ON, Canada

One in six Canadian couples of childbearing age experience fertility challenges[i], this number has doubled since the 1980s.[ii] April 22 to 27 is Canadian Infertility Awareness Week, and EMD Serono, Canada is bringing attention to the far-reaching impact of infertility to encourage couples to educate themselves on reproductive health and family planning.

Infertility can be defined as a failure to achieve a clinical pregnancy after 12 months of attempted conception without contraception. A fertility consultation may be recommended after one year of attempted conception for women under 35 years of age and 6 months for women over 35 years of age.[iii] Age, length of time you have been trying to conceive, hormone levels, medical history and other factors can all contribute to fertility.[iv]  

“When my husband and I found out we were going to need help staring our family, we had no idea what to expect,” said Breya Rolt, first-time mom from Burlington, Ontario. “No one really talks about fertility issues until you are thrown into it. When we opened up about our experience, we were surprised to learn just how many people were in the same boat.”

YouTube: Watch as Breya and Dan share their journey to starting a family.

Fertility challenges are often viewed as an issue affecting the female reproductive system, but men are almost just as likely as women to experience fertility challenges.[vi] Fertility specialists can make recommendations to help couples conceive naturally or with assisted reproductive technology. But some couples may delay or decline treatments due to the perceived social stigma associated with fertility challenges.

“Making the decision to start a family is usually a pretty private thing and it can feel like you are losing some of that privacy when you have to reach out for help. But what we lost in privacy, we gained in support. We are grateful for the team of doctors and nurses at our fertility clinic who helped us make our dream of starting a family come true,” said Rolt.  

It is important for couples trying to conceive to educate themselves on their reproductive health and fertility options.

“It is never too early to talk to your family doctor or OB/GYN about fertility,” said Dr. Shannon Corbett, Medical Director and Partner, The Reproductive Care Centre. “Learning about your reproductive health is an important part of family planning. Couples trying to conceive are encouraged to have these conversations with their doctor so they can understand their options and make the best decision for themselves and their family at any stage of their fertility journey.”

For information and resources on fertility, visit www.positiveplan.ca.

 

For more information, or to arrange an interview, please contact:

Samantha Ouimet
EMD Serono Canada

Head of Communications, Canada
905.919.0296
samantha.ouimet@emdserono.com

About Infertility

An estimated one in six Canadian couples of childbearing age experience fertility challenges.[i] Infertility can be defined as a failure to achieve a clinical pregnancy after 12 months of attempted conception without contraception. A fertility consultation may be recommended after one year of attempted conception for women under 35 years of age and 6 months for women over 35 years of age.[ii]

Fertility challenges can affect both men and women, or a combination of both. Causes of fertility issues in men may include poor sperm quality, low sperm count, a history of sexually transmitted disease and a hormonal imbalance.[iii] Potential causes for women include age (fertility decreases after age 35), problems producing eggs, a history of sexually transmitted diseases, problems in the uterus or fallopian tubes, endometriosis, hormonal imbalances and early menopause.[iv]

 

About EMD Serono, Canada

EMD Serono, Canada, is the Canadian biopharmaceutical business of Merck KGaA, Darmstadt, Germany. EMD Serono, Canada has integrated cutting-edge science, innovative products and devices, and industry-leading patient support and access programs. EMD Serono, Canada has deep expertise in neurology, fertility and endocrinology, as well as a robust pipeline of potential therapies in neurology, oncology, immunology and immuno-oncology. Today, EMD Serono, Canada has more than 100 employees across Canada with headquarters in Mississauga, Ontario.

 

About Merck KGaA, Darmstadt, Germany

Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. Around 52,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2018, Merck KGaA, Darmstadt, Germany, generated sales of € 14.8 billion in 66 countries.

The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.

 

[i] Government of Canada. Fertility. Accessed March 14, 2019. Available at: https://www.canada.ca/en/public-health/services/fertility/fertility.html

[ii] Government of Canada. Fertility. Accessed March 14, 2019. Available at: https://www.canada.ca/en/public-health/services/fertility/fertility.html

[iii] Government of Canada. Fertility. Accessed March 14, 2019. Available at: https://www.canada.ca/en/public-health/services/fertility/fertility.html

[iv] Government of Canada. Fertility. Accessed March 14, 2019. Available at: https://www.canada.ca/en/public-health/services/fertility/fertility.html

[v] Government of Canada. Fertility. Accessed March 14, 2019. Available at: https://www.canada.ca/en/public-health/services/fertility/fertility.html

[vi] Government of Canada. Fertility. Accessed March 14, 2019. Available at: https://www.canada.ca/en/public-health/services/fertility/fertility.html

[vii] Government of Canada. Fertility. Accessed March 14, 2019. Available at: https://www.canada.ca/en/public-health/services/fertility/fertility.html

[viii] Government of Canada. Fertility. Accessed March 14, 2019. Available at: https://www.canada.ca/en/public-health/services/fertility/fertility.html

[ix] Government of Canada. Fertility. Accessed March 14, 2019. Available at: https://www.canada.ca/en/public-health/services/fertility/fertility.html

[x] Government of Canada. Fertility. Accessed March 14, 2019. Available at: https://www.canada.ca/en/public-health/services/fertility/fertility.html    

Redirect

You have accessed emdserono.ca, but for users from your part of the world, we originally designed the following web presence merckgroup.com

Let's go

Site Exit Disclaimer

You are now leaving the website of Merck KGaA, Darmstadt, Germany’s biopharma business. This link may lead to a resource maintained by third parties over whom we have no control. As such, we are not responsible for and makes no representation as to the accuracy or any other aspect of such resource or the privacy practices of such third party. Providing links to a third party website does not constitute an endorsement by our company of such website or the information or products presented on such website.

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement